SG
ARKG icon

StoneX Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

StoneX Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
+4,796
New +$153K 0.01% 1093
2026
Q1 		– Sell
-8,746
Closed -$253K – 932
2025
Q4 		$253K Buy
8,746
+530
+6% +$15.9K 0.01% 772
2025
Q3 		$228K Sell
8,216
-847
-9% -$21.4K 0.01% 785
2025
Q2 		$221K Buy
+9,063
New +$199K 0.01% 748
2024
Q4 		– Sell
-8,045
Closed -$206K – 866
2024
Q3 		$206K Sell
8,045
-888
-10% -$22.6K 0.02% 582
2024
Q2 		$210K Buy
8,933
+652
+8% +$16.5K 0.02% 559
2024
Q1 		$238K Buy
8,281
+238
+3% +$7.16K 0.02% 485
2023
Q4 		$264K Sell
8,043
-73
-0.9% -$1.99K 0.03% 448
2023
Q3 		$226K Buy
8,116
+54
+0.7% +$1.76K 0.02% 487
2023
Q2 		$275K Buy
8,062
+982
+14% +$30.9K 0.03% 428
2023
Q1 		$213K Buy
+7,080
New +$219K 0.02% 517
2022
Q4 		– Sell
-12,054
Closed -$396K – 704
2022
Q3 		$396K Sell
12,054
-703
-6% -$25.8K 0.05% 315
2022
Q2 		$402K Buy
12,757
+1,641
+15% +$57.4K 0.05% 339
2022
Q1 		$511K Buy
11,116
+1,303
+13% +$62.1K 0.04% 354
2021
Q4 		$601K Buy
9,813
+1,005
+11% +$69.5K 0.07% 260
2021
Q3 		$658K Buy
8,808
+259
+3% +$21.7K 0.09% 211
2021
Q2 		$791K Buy
8,549
+1,142
+15% +$97.1K 0.12% 184
2021
Q1 		$657K Sell
7,407
-4,018
-35% -$399K 0.12% 175
2020
Q4 		$1.06M Buy
11,425
+2,722
+31% +$217K 0.23% 85
2020
Q3 		$554K Buy
8,703
+3,786
+77% +$222K 0.18% 135
2020
Q2 		$256K Buy
+4,917
New +$211K 0.1% 232

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

StoneX Group's ARKG Position: Q2 2026 in Review

StoneX Group opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 4,796 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #1093 among its holdings. This is a return to the name: StoneX Group previously reported a position in ARKG as recently as Q4 2025.

StoneX Group first reported a position in ARKG in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.06M in Q4 2020. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • StoneX Group held 4,796 shares of ARK Genomic Revolution ETF worth $202K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new StoneX Group position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.01% of StoneX Group's portfolio in Q2 2026, its #1093 holding.
  • StoneX Group first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 21 quarters since.
  • StoneX Group's ARK Genomic Revolution ETF position peaked at $1.06M in Q4 2020.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.